A facile, scalable preparation of 4-chloro-2-iodothieno[2,3-b]pyridine-5-carbonitrile

ORGN 741

L. Nathan Tumey, tumeyn@wyeth.com, Biqi Wu, and Diane H. Boschelli. Chemical & Screening Sciences, Wyeth Research, 401 N. Middletown Rd., Pearl River, NY 10965
We previously reported that a 7-phenylaminothieno[3,2-b]pyridine-6-carbonitrile analog was a more potent Src kinase inhibitor than the corresponding 4-phenylaminothieno[2,3-b] isomer.  In studying these two bicyclic cores as templates for the inhibition of a different kinase, improved activity was observed with the [2,3-b] isomer.  To facilitate the preparation of these analogs, an improved route to a key intermediate, 4-chloro-2-iodothieno[2,3-b]pyridine-5-carbonitrile (1), was required.  In our original preparation of 1, 2-nitrothiophene was converted in 3 steps to ethyl 4-chlorothieno[2,3-b]pyridine-5-carboxylate, with an additional 4 steps being needed to obtain the desired product.  We report here a 5 step synthesis of 1 from a commercially available starting material that provides 1 in an overall yield of 48%.  Optimization of this route and the synthesis of various C-3 substituted analogs will also be described.